Amid Carnage In Group, These Biotechs Stand Out

By | May 28, 2014

Scalper1 News

A new all-time closing high for the S&P 500 on Tuesday and a 1.2% gain for the Nasdaq put the market back in a confirmed uptrend. One of the best-performing industry groups that day was IBD’s Medical-Biomed/Biotech group, which rose 2.8%. As of Tuesday’s close, the group still stood in the top quartile out of 197 groups ranked by IBD based on six-month price performance. The group recently pulled back 30% off its high and is firming up around its Scalper1 News

Scalper1 News